Cleo Diagnostics Ltd is a medical diagnostics/devices entity focussed on the development of non-invasive blood based IVD tests to detect the presence, and recurrence, of ovarian cancer. The Company has developed a three-phased product development strategy that will deliver three related tests for ovarian cancer detection which includes Triage Test, Recurrence Test and Screening Test.